Recent Investments/Transactions

Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
21 min read

Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

Read More  

Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors

Read More  
12 min read
Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors
9 min read

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Read More  
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
8 min read

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Read More  
Black Titan Secures $200 Million from a U.S.-Based Institutional Investor to Scale Its DAT+ Vision
3 min read

Black Titan Secures $200 Million from a U.S.-Based Institutional Investor to Scale Its DAT+ Vision

Read More  
Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales
3 min read

Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales

Read More  
Sow Good Inc. Announces $6.0 Million Private Placement, Strategic Asset Sale, and Leadership Transition to Support Continued Candy Operations and Future Growth:
8 min read

Sow Good Inc. Announces $6.0 Million Private Placement, Strategic Asset Sale, and Leadership Transition to Support Continued Candy Operations and Future Growth:

Read More  
Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar
1 min read

Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar

Read More  
KALA Bio’s Bold Move: A New Dawn?
4 min read

KALA Bio’s Bold Move: A New Dawn?

Read More  
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
13 min read

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Read More  
Why Did KALA BIO Shares Jump Over 22% After Hours?
13 min read

Why Did KALA BIO Shares Jump Over 22% After Hours?

Read More  
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
17 min read

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Read More